IRELAND – Irish biotechnology company Nuritas has collaborated with Nestlé to research bioactive peptide networks within specific target areas.
In order to achieve the common goal, Nuritas will deploy its technology platform, which uses artificial intelligence and DNA analysis to predict, unlock, and validate highly efficacious peptides, exclusively from natural food sources.
According to NutraIngredients, Nestlé will use its scientific know-how and applications expertise to validate the efficacy of these new discoveries within the target applications.
“At Nuritas our mission is to positively impact billions of lives worldwide and we therefore are delighted to be collaborating with Nestlé, the world’s largest food and beverage company on such an important project.
We are really looking forward to beginning this impactful journey together,” said Nuritas founder and chief scientific officer Nora Khaldi.
Richard Stadler at the Nestlé Research Centre also commented, “As our understanding of food and nutrition continues to grow, our global research and development network is looking ahead to discover how we can help enhance quality of life and contribute to a healthier future for everyone.
Research partnerships such as that with Nuritas help us achieve that goal.”
Nuritas CEO Emmet Browne also added that the fruition of the collaboration carried the promise to be truly industry-changing.
He added that they were very excited to partner with Nestlé as they look to continue their own admirable purpose to help shape a better and healthier world.
The news follows on from a similar announcement last year that Nuritas would partner with BASF Human Nutrition to focus on peptide networks that are natural, food-derived, patented and beneficial to the health of consumers.
